Vanguard Group’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $706K | Sell |
|
|||||
|
2025
Q1 | $631K | Sell |
|
|||||
|
2024
Q4 | $1.08M | Sell |
|
|||||
|
2024
Q3 | $3.32M | Hold |
|
|||||
|
2024
Q2 | $2.58M | Sell |
|
|||||
|
2024
Q1 | $7.22M | Buy |
|
|||||
|
2023
Q4 | $5.12M | Sell |
|
|||||
|
2023
Q3 | $3.57M | Buy |
|
|||||
|
2023
Q2 | $6.29M | Buy |
|
|||||
|
2023
Q1 | $5.15M | Sell |
|
|||||
|
2022
Q4 | $15.9M | Buy |
|
|||||
|
2022
Q3 | $10.8M | Buy |
|
|||||
|
2022
Q2 | $3.26M | Sell |
|
|||||
|
2022
Q1 | $7.78M | Sell |
|
|||||
|
2021
Q4 | $44.5M | Buy |
|
|||||
|
2021
Q3 | $61.5M | Buy |
|
|||||
|
2021
Q2 | $44.4M | Buy |
|
|||||
|
2021
Q1 | $51M | Buy |
|
|||||
|
2020
Q4 | $2.55M | Buy |
|